Francisco Mateos

Potential application of silver nanoparticles to control the infectivity of Rift Valley fever virus in vitro and in vivo

Belén Borrego, Gema Lorenzo, Josué D. Mota‐Morales et al. · Nanomedicine Nanotechnology Biology and Medicine · 2016 · 131 citations

Life Sciences, Infectious Diseases, Microbiology +10

Protection of IFNAR (−/−) Mice against Bluetongue Virus Serotype 8, by Heterologous (DNA/rMVA) and Homologous (rMVA/rMVA) Vaccination, Expressing Outer-Capsid Protein VP2

Tamara Jabbar, Eva Calvo-Pinilla, Francisco Mateos et al. · PLoS ONE · 2013 · 51 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Development and characterization of monoclonal antibodies against Rift Valley fever virus nucleocapsid protein generated by DNA immunization

Raquel Martín-Folgar, Gema Lorenzo, Hani Boshra et al. · mAbs · 2010 · 45 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Self-Assembly of the Recombinant Capsid Protein of a Swine Norovirus into Virus-Like Particles and Evaluation of Monoclonal Antibodies Cross-Reactive with a Human Strain from Genogroup II

Horacio Almanza‐Reyes, Carolina Cubillos‐Zapata, Ivan L. Ângulo et al. · Journal of Clinical Microbiology · 2008 · 38 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Ns1 Is a Key Protein in the Vaccine Composition to Protect Ifnar(−/−) Mice against Infection with Multiple Serotypes of African Horse Sickness Virus

F. Poza, Eva Calvo-Pinilla, Elena López-Gil et al. · PLoS ONE · 2013 · 32 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17